All News #Library
Sciences
Novo Holdings` antibiotic resistance fund backs 3 biotechs
21 Jan 2019 //
FIERCE BIOTECH
Entasis Therapeutics and the Global Antibiotic Research & Development Partnership
22 Nov 2018 //
PRESS RELEASE
Entasis Therapeutics Announces Zoliflodacin Phase 2 Results Published in NEJM
07 Nov 2018 //
GLOBENEWSWIRE

Market Place
Sourcing Support